Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents
Related Experiment Video
Updated: May 9, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Stéphanie Vandekerckhove1, Hai Giang Tran, Tom Desmet
1SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent, Belgium.
Abstract:
Antifungal assessment of eighteen 5-, 6- and 8-(4-aminobutyloxy)quinolines revealed a significant susceptibility of the tested fungi and yeast strains (Candida albicans, Rhodotorula bogoriensis, Aspergillus flavus and Fusarium solani) toward different halo-substituted 8-(4-aminobutyloxy)quinolines. The six most potent compounds displayed antifungal activities similar to those of established antifungal agents such as Amphotericin B, Fluconazole and Itraconazole, and one representative also showed a promising broad-spectrum antifungal profile. The introduction of an aminoalkoxy side chain at the 8-position of a halo-substituted quinoline core might thus provide a new class of lead structures in the search for novel antifungal agents.
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing

